3:20 AM
 | 
Dec 06, 2017
 |  BC Extra  |  Financial News

Obsidian raises $49.5M series A

After two years in stealth mode, Obsidian Therapeutics Inc. (Cambridge, Mass.) emerged with a $49.5 million series A round led by GV. Fellow new investors Takeda Ventures Inc., Vertex Ventures HC, Amgen Ventures and ShangPharma Investment Group also participated, as did founding investor Atlas Venture and existing investor Alexandria...

Read the full 222 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >